Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
American Gene Technologies International
company
About
AGT is pioneering gene therapy solutions to achieve permanent cures for human diseases, including a possible cure for HIV in clinical trials
- 11 - 50
Details
- Last Funding Type
- Series D
- Last Funding Money Raised
- $16.40M
- Industries
- Biotechnology,Genetics,Health Care,Medical,Pharmaceutical
- Founded date
- Jan 1, 2008
- Number Of Employee
- 11 - 50
- Operating Status
- Active
American Gene Technologies (AGT) is focused on creating long-term value for patients, society, investors and donors by developing and testing cutting-edge gene therapies to cure some of humanity’s worst diseases. AGT’s HIV cure clinical trial could not only lead to a blockbuster drug that brings relief to one of society's most elusive epidemics, but it could prove the efficiency and effectiveness of AGT’s platform technologies to cure dozens of diseases ranging from viruses to cancers.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$20.50M
American Gene Technologies International has raised a total of
$20.50M
in funding over 2 rounds. Their latest funding was raised on
Feb 1, 2016 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 1, 2016 | Series D | $16.40M | 1 |
Gaingels
|
— | Detail |
| Feb 20, 2015 | Series C | $4.10M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
American Gene Technologies International is funded by 2 investors.
Gaingels
and National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Gaingels
|
Yes | Series D |
National Institutes of Health
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
